# MPX Bioceutical Corp — Form D

MPX Bioceutical Corp of TORONTO, A6, a company, filed a Form D exempt-offering notice with the SEC on 2018-01-22. The offering totals $2.5M, of which $2.5M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2018-01-22
- Form: D
- Accession: 0001728215-18-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $2.5M
- Amount sold: $2.5M
- Investors: 20
- Date of first sale: 2017-01-19
- Security types: equity
- Revenue range: $1,000,001 - $5,000,000
- SEC file number: 021-303844

## Issuer

- Name: MPX Bioceutical Corp
- CIK: 0001728215
- Entity type: Corporation
- Jurisdiction: ONTARIO, CANADA
- Address: 5255 YONGE STREET, SUITE 701, TORONTO, A6, M2N 6P4
- Phone: (416) 840-3725

## Officers, directors & promoters (11)

| Name | Role | Location |
| --- | --- | --- |
| W. Scott Boyes | Director | Toronto, A6 |
| Robert R Galvin | Director | Toronto, A6 |
| Andrew R Ryan | Director | Toronto, A6 |
| Richard S Segerblom | Director | Toronto, A6 |
| Randall G Stafford | Director | Toronto, A6 |
| Elizabeth M Stavola | Director | Toronto, A6 |
| Miles D Thompson | Director | Toronto, A6 |
| W. Scott Boyes | Executive Officer | Toronto, A6 |
| Jeremy S Budd | Executive Officer | Toronto, A6 |
| David S McLaren | Executive Officer | Toronto, A6 |
| Elizabeth M Stavola | Executive Officer | Toronto, A6 |

## More

- [CIK 1728215 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1728215&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001728215-18-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.